Vollversion der ÖDG-Leitlinien 2012
Vollversion der ÖDG-Leitlinien 2012
Vollversion der ÖDG-Leitlinien 2012
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
leitlinien für die praxis<br />
26. Martin CL, Albers J, Herman WH, et al. Neuropathy among<br />
the Diabetes Control and Complications Trial Cohort 8<br />
years after trial. Diabetes Care. 2006;29:340–4.<br />
27. Gremizzi C, Vergani A, Paloschi V, Secchi A. Impact of pancreas<br />
transplantation on type 1 diabetes-related complications.<br />
Curr Opin Organ Transplant. 2010;15:119–23.<br />
28. UK Prospective Diabetes (UKPDS) Group. Intensive<br />
blood-glucose control with sulfonylureas or insulin compared<br />
with conventional treatment and rate of complication<br />
in patients with type 2 diabetes (UKPDS 33). Lancet<br />
1998;12:837–63.<br />
29. Holman RR, Paul SK, Bethal MA, et al. 10-years follow-up<br />
of intensive glucose control in type 2 diabetes. N Engl J<br />
Med. 2008;359:1577–84.<br />
30. Amthor KF, Dahl-Jorgensen K, Berg TJ, et al. The effect<br />
of 8 years of strict glycaemic control on peripheral nerve<br />
function in IDDM patients. The Oslo study. Diabetologia<br />
1994;37:579–84.<br />
31. Reichard P, Pihl M, Rosenqvist U, Sule J. Complications<br />
in IDDM are caused by elevated blood glucose levels:the<br />
Stockholm Diabetes Intervention Study (SDIS) at 10-years<br />
follow up. Diabetologia 1996;31:1483–8.<br />
32. ADVANCE Collaborative Group. Intensive blood glucose<br />
control and vascular outcome in patients with type 2 diabetes.<br />
N Engl J Med. 2008;358:2560–72.<br />
38 Die diabetische Neuropathie<br />
33. Duckworth W, Abraira C, Moritz T, et al. Intensive glucose<br />
control and complications in American Veterans with type<br />
2 diabetes. N Engl J Med. 2009;8:129–39.<br />
34. Ziegler D. Treatment of diabetic neuropathy and neuropathic<br />
pain. Diabetes Care. 2008;31(Suppl 2):255–61.<br />
35. Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of<br />
antioxidant treatment with alpha-lipoic acid over 4 years in<br />
diabetic polyneuropathy: the Nathan 1 trial. Diabetes Care.<br />
2011;34:2054–60.<br />
36. McIlduff CE, Rutkove SB. Critical appraisal of the use of<br />
alpha lipoic acid (thioctic acid) in the treatment of symptomatic<br />
diabetic polyneuropathy. Ther Clin Risk Manag.<br />
2011;7:377–85.<br />
37. Ziegler D. Treatment of diabetic neuropathy: update 2006.<br />
Ann N Y Acad Sci. 2006;1084:250–68.<br />
38. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin<br />
for acute and chronic pain in adults. Cochrane Database<br />
Syst Rev. 2009;8:CD007076.<br />
1 3
Change language